Last reviewed · How we verify
NCT07452718
Effests of Minimalist Footwear on Healthy Subjects.
NA trial testing Minimalist footwear (Saguaro) in Healthy Adult Participants in 90 participants. Completed in 12 December 2025.
30 November 2025
Quick facts
| Lead sponsor | University of Salamanca |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 90 |
| Start date | 1 April 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 12 December 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Minimalist footwear (Saguaro)
Conditions studied
- Healthy Adult Participants — all drugs for Healthy Adult Participants →
Sponsor
University of Salamanca
Who can join
18 and older, any sex, with Healthy Adult Participants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: There is evidence showing that wearing minimalist footwear offers multiple short-term advantages for the musculoskeletal system, both locally and regionally, compared to traditional footwear. However, little research has been done on the medium- and long-term effects of wearing minimalist footwear. So, the aim of the study is to assess the long-term effects of wearing minimalist footwear on various variables measured in healthy subjects. Materials and methods: A randomized, single-blind, controlled clinical trial is conducted. A sample of 80 healthy adults is randomly divided into an experimental group (wearing minimalist footwear) and a control group (wearing traditional footwear). The study variables are measured before and after the intervention. The outcomes are morphology and function of the intrinsic foot muscles (IFMs), study of plantar pressures under load, static and dynamic stability, thickness and compressibility of the heel fat pad, frontal plane alignment of the metatarsophalangeal joint of the hallux, and plantar skin sensitivity. Applicability of the expected results: If positive changes are found in the experimental group, it is proposed that educational talks or other types of actions be organized to promote the use of this type of footwear.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07452718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Adult Participants
Currently open trials in the same condition.
- NCT07352423 — Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants · Phase 1 · recruiting
- NCT07522333 — Psychological Impact of an 120-km Ultra-Endurance Race · recruiting
- NCT07522307 — Psychological Impact of an 80-km Ultra-Endurance Race · recruiting
- NCT07483606 — Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool · recruiting
- NCT07357610 — An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healt · Phase 1 · recruiting
Other University of Salamanca trials
Trials by the same sponsor.
- NCT07359495 — Multicomponent Training and Muscle Quality in Older Women · NA · not yet recruiting
- NCT07286539 — Precision Physical Exercise for Personalized Onco-Hematology. · NA · not yet recruiting
- NCT07387770 — Muscle Deterioration in Hospitalized Cancer Patient · NA · not yet recruiting
- NCT07387757 — Exergames in Mental Health · NA · not yet recruiting
- NCT07333768 — EQUISOCK: New Antiequine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07452718 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Salamanca
- Last refreshed: 5 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07452718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing